LBA7 Neoadjuvant immune checkpoint inhibition in locally advanced MMR-deficient colon cancer: The NICHE-2 study von Chalabi, M., Verschoor, Y.L., van den Berg, J., Sikorska, K., Beets, G., Lent, A.V., Grootscholten, M.C., Aalbers, A., Buller, N., Marsman, H., Hendriks, E., Burger, P.W.A., Aukema, T., Oosterling, S., Beets-Tan, R., Schumacher, T.N., van Leerdam, M., Voest, E.E., Haanen, J.B.A.G.

Volltext

412P Phase I study of intraperitoneal irinotecan in combination with standard systemic chemotherapy in patients with extensive peritoneal metastases of colorectal origin: The INTER... von Van Eerden, R.A.G., De Boer, N.L., van Kooten, J.P., Bakkers, C., Dietz, M.V., Creemers, G-J.M., Buijs, S.M., Bax, R., de Man, F.M., Lurvink, R.J., Diepeveen, M., Brandt-Kerkhof, A.R.M., van Meerten, E., Koolen, S.L., de Hingh, I.H.J.T., Verhoef, K., Mathijssen, R.H., Burger, P.W.A.

Volltext